GIOTRIF as monotherapy is indicated for the treatment of Epidermal Growth Factor Receptor (EGFR) TKI-naïve adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating EGFR mutation(s).
Rapid Review
Commenced | Completed | Outcome |
01/10/2013 | 13/10/2013 | Full HTA not recommended |